LOS ANGELES - Arizonar -- The State of California has imposed additional licenses, more stringent standards, and thorough inspections for compounding pharmacies, and it has become increasingly difficult for healthcare providers to obtain sterile medications from 503A and 503B compounding pharmacies for both legal and economic reasons. The additional and more stringent requirements imposed by California law have led to a lack of and need for IV-specific compounding pharmacies existing in California and outside of California that can ship into California.

Some compounding pharmacies only offer non-sterile products and some only dabble in certain areas. Therein lies one problem for IV hydration therapy providers in California. Only one sterile pharmacy that produces IV therapy treatments can sell such treatments to California healthcare providers. While some may think that should solve the problem, many providers may not know about this pharmacy or are on the hunt for less costly product. It's not surprising that California healthcare providers are rebelling. Some providers, on their own, and even at the direction of certain compounding pharmacies, have set up PO boxes in neighboring states, like Nevada, to ship medications to and then transport over state lines into California. Other providers are allocating patient-specific prescriptions across multiple patients.

More on The Arizonar

• Databloom's Blossom Achieves Faster and More Efficient Big Data Analytics
• Elite Imagined High Net Worth Branding Online Reputation Management Expanding Into Malaysia Market
• Orchard Audio's New PecanPi®+ DAC and Streamer Feature AKM's Latest Flagship Chips
• Country Artist Ashley Wineland to Release Poignant Ballad 'I'm Going Home'; Announces Her 2023 National Tour
• Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference

"It should seem obvious that if you have to get "creative," either the system or program within which you are acting is flawed, or you probably shouldn't be doing what you're doing. In this case, it could be both. Where does all this regulation and creativity leave healthcare providers? Any healthcare provider purchasing, lending their license for purchasing and/or administering medication improperly sourced is, at the very least, at risk for loss of their license. In fact, to say "at risk" is an understatement. They may also very well be charged and convicted of a misdemeanor or felony, and subject to fines," says Amanda Howard, Attorney at Florida Healthcare Law Firm in Delray Beach, FL and legal contribution author for AIVA.

Howard goes on with a message that mirrors other trade experts who believe the time is now for the IV hydration therapy industry to self-regulate. "The day an improperly sourced IV hydration therapy treatment causes a severe reaction, or fatal threat to a Californian, the very people the Board seeks to protect, expect a reckoning. If, of course, it doesn't come before. Access will be even more restricted than it is now. The bad players AND good players will suffer the consequences."

More on The Arizonar

• Doug Brownridge Joins STS Capital Partners
• CSC Motorcycles Announces New Twin Cylinder 650cc Sport Touring Model
• Cargill joins Selerant on stage at American Food Innovate 2023
• The In-N-Out Burger Financial Planning Story
• Cash Depot Appoints Tony Gaines as Chief Revenue Officer and Brand Ambassador

AIVA is the leading industry beacon for providers of IV hydration therapy services nationwide. Through our network of legal resources and industry-leading professional expertise we provide unparalleled business resources for owners and operators providing IV therapy services. AIVA's membership and website resources will be launched in the coming weeks, with an initial launch in the following states: Florida, California, Texas, Georgia, Nevada, New York, Arizona, North Carolina, Ohio Michigan. Contact: gina@americaniv.com, call (561) 757-4430 ext. 102 or visit: https://americaniv.com/mpage/home